Immunogenicity and Safety of a Newly Developed Tetanus-Diphtheria Toxoid (Td) in Healthy Korean Adolescents: a Multi-center, Randomized, Double-blind, Active-Controlled Phase 3 Trial.

Published in: Journal of Korean medical science (2021)

ClinicalTrials.gov Identifier: NCT04618939.

Keyphrases